Resultats de la cerca - Xiaohua Gong

Evaluation of the clinical cardiac safety of pemigatinib, a fibroblast growth factor receptor inhibitor, in participants with advanced malignancies per Xiaohua Gong, Tao Ji, Xiang Liu, Xuejun Chen, Swamy Yeleswaram

Connect to this object online.

The impact of multidisciplinary team nutrition management on nutritional and toxicity status in patients with nasopharyngeal carcinoma per Xueqing Ou, Hui Chen, Ting Qiu, Yajun Yuan, Xiaohua Gong

Connect to this object online.

Evaluation of the cardiac safety of parsaclisib, a selective PI3Kδ inhibitor, in patients with previously treated B‐cell malignancies: Results from the CITADEL‐101 study per Jia Li, Xiaohua Gong, Xing Liu, Xiang Liu, Ke Szeto, Xuejun Chen

Connect to this object online.

Population pharmacokinetic and exposure‐response analyses of pemigatinib in patients with advanced solid tumors including cholangiocarcinoma per Xiaohua Gong, Ayman Akil, Andre Ndi, Tao Ji, Xiang Liu, Mark Lovern, Xuejun Chen

Connect to this object online.